V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011758 | 280006412 | 1.87 | null | Palliative (P) | 2016-12-03 | 2017-06-07 | CETUXIMAB + IRINOTECAN + MDG | N | N | 280030190 | CARBO + FLUOROURACIL |
| 280011759 | 280006421 | null | 74.8 | Palliative (P) | 2013-05-29 | 2014-04-15 | IVADo | null | null | 280030215 | ECX |
| 280011760 | 280006432 | 1.82 | 56.7 | Palliative (P) | 2014-07-28 | 2015-01-25 | Capecitabine | N | N | 280030225 | BUSULFAN + MELPHALAN |
| 280011761 | 280009360 | 1.47 | 64 | Palliative (P) | 2018-05-27 | 2018-06-06 | Capecitabine | Y | N | 280030257 | TRASTUZUMAB |
| 280011762 | 280010764 | null | 89.6 | Disease modification (D) | 2018-12-27 | 2019-01-01 | Cisplatin + Fluorouracil + RT 5day | N | Y | 280030265 | VINORELBINE |
| 280011763 | 280012084 | null | 65.5 | Palliative (P) | 2017-04-25 | 2017-05-18 | Ipilimumab | N | N | 280030339 | DACARBAZINE |
| 280011764 | 280006475 | 1.76 | 70 | Palliative (P) | 2017-09-17 | 2017-09-30 | Doxorubicin + Gemcitabine | 2 | N | 280030360 | CARBOPLATIN + CETUXIMAB |
| 280011765 | 280006479 | 1.8 | 19.9 | Adjuvant (A) | 2019-02-04 | 2019-02-26 | Etoposide IV | n | N | 280030373 | RITUXIMAB |
| 280011766 | 280006487 | 1.8 | null | Palliative (P) | 2016-09-15 | 2018-04-22 | OST Euramos 1 Closed Trial - M | 02 | N | 280030387 | CARBOPLATIN + LIPOSOMAL DOX |
| 280011767 | 280006503 | null | 63.4 | Palliative (P) | 2016-10-18 | 2016-11-02 | NIVOLUMAB | N | N | 280030464 | DACARBAZINE |
| 280011768 | 280009390 | 1.77 | 98 | Palliative (P) | 2013-02-20 | 2013-12-02 | PEMBROLIZUMAB | N | N | 280030483 | IVADO |
| 280011769 | 280006516 | null | 74.3 | Palliative (P) | null | 2018-04-24 | IVADo | 2 | N | 280030509 | CYCLOPHOSPHAMIDE + MTX |
| 280011770 | 280006530 | 1.52 | null | Palliative (P) | 2018-01-22 | 2018-01-29 | INTERFERON | N | N | 280030568 | VIDE |
| 280011771 | 280011462 | 1.57 | 52.3 | Palliative (P) | 2014-12-29 | 2014-12-30 | EOX | Y | N | 280030599 | DOCETAXEL |
| 280011772 | 280006557 | 1.8 | null | Curative (C) | 2017-09-20 | 2017-10-12 | BUSULFAN + MELPHALAN | 2 | N | 280030686 | DACTINOMYCIN + VINCRISTINE |
| 280011773 | 280006569 | 1.87 | 82.9 | Palliative (P) | 2019-05-24 | 2019-06-05 | IVADo | N | N | 280030702 | CISPLATIN + FLUOROURACIL + RT |
| 280011774 | 280006572 | 1.62 | 62.1 | Palliative (P) | 2018-07-21 | 2018-08-08 | NIVOLUMAB | 02 | null | 280030705 | DACTINOMYCIN + VINCRISTINE |
| 280011775 | 280006579 | 1.89 | 61.8 | null | 2015-05-22 | 2015-06-23 | Dactinomycin + Vincristine | 2 | N | 280030712 | ETOPOSIDE |
| 280011776 | 280006584 | null | 52.5 | Palliative (P) | 2017-06-26 | 2018-06-07 | Vinorelbine IV | null | null | 280030724 | AXI-STS TRIAL |
| 280011777 | 280006591 | 1.63 | 91.7 | Curative (C) | 2017-08-06 | 2017-12-09 | Cyclophosphamide High Dose | 2 | N | 280030761 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280011778 | 280006596 | 1.71 | 100.5 | Palliative (P) | 2018-07-07 | 2018-08-08 | CASPS TRIAL | N | N | 280030774 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280011779 | 280009433 | 1.87 | 54 | Palliative (P) | 2018-02-10 | 2019-07-17 | PEI | 02 | N | 280030791 | CISPLATIN + DOXORUBICIN |
| 280011780 | 280006604 | 1.53 | 53.8 | Palliative (P) | 2015-12-20 | 2016-02-03 | Cyclophosphamide + Vincristine | 2 | N | 280030812 | VINCRISTINE |
| 280011781 | 280009443 | 1.6 | null | Palliative (P) | 2019-08-04 | 2019-08-10 | PEMBROLIZUMAB | N | N | 280016663 | AVELUMAB |
| 280011782 | 280006622 | 1.89 | 56.7 | Palliative (P) | 2015-09-01 | 2015-09-04 | BLEOMYCIN + CISPLATIN + VINCRISTINE | null | null | 280018042 | VIA |
| 280011783 | 280011474 | 1.75 | 71.5 | Disease modification (D) | null | 2018-05-23 | BCG Intravesical | N | N | 280019073 | CAPECITABINE |
| 280011784 | 280006639 | 1.82 | null | Palliative (P) | null | 2017-08-10 | Cisplatin + Fluorouracil + RT 5day | 02 | null | 280019450 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280011785 | 280006654 | 1.67 | 101.7 | Palliative (P) | 2015-12-09 | 2015-12-15 | MITOMYCIN | N | N | 280020096 | BENDAMUSTINE + RITUXIMAB |
| 280011786 | 280006661 | null | 51.3 | Palliative (P) | null | 2016-06-15 | Pazopanib | 02 | N | 280020449 | BCG |
| 280011787 | 280006663 | 1.56 | 55.3 | Palliative (P) | 2013-06-19 | 2014-01-28 | LANREOTIDE | null | null | 280020492 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280011788 | 280006670 | 1.75 | 96 | null | 2018-10-06 | 2018-10-06 | BCG Intravesical | null | null | 280020669 | BCG |
| 280011789 | 280006676 | 1.77 | 94 | Palliative (P) | 2014-12-03 | 2015-01-18 | IVADo | 02 | N | 280020851 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011790 | 280006684 | 1.7 | 63.4 | Palliative (P) | 2019-03-03 | 2019-03-03 | Ipilimumab | null | null | 280021411 | DOXORUBICIN + GEMCITABINE |
| 280011791 | 280006695 | 1.87 | 67 | Palliative (P) | 2016-06-13 | 2016-06-16 | Cisplatin + Fluorouracil + RT 5day | 02 | Y | 280022533 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280011792 | 280009477 | 1.71 | 83.95 | Disease modification (D) | 2019-05-11 | 2019-06-06 | CARBOPLATIN + GEMCITABINE | 02 | N | 280022830 | ABVD |
| 280011793 | 280006712 | 1.79 | 100.2 | Neo-adjuvant (N) | null | 2015-07-30 | CTD | N | N | 280023280 | LIPOSOMAL DOXORUBICIN |
| 280011794 | 280006717 | 1.65 | 77 | Palliative (P) | 2018-07-24 | 2018-09-26 | VIDE | N | N | 280023299 | GEFITINIB |
| 280011795 | 280009491 | 1.58 | 47 | Palliative (P) | 2019-05-18 | 2019-05-21 | Pemetrexed | N | N | 280023443 | BUSULFAN + MELPHALAN |
| 280011796 | 280006727 | 1.86 | 93 | Palliative (P) | 2018-06-26 | 2018-07-09 | IPILIMUMAB + NIVOLUMAB | N | Y | 280024160 | VIDE |
| 280011797 | 280006751 | 1.8 | 65 | Palliative (P) | 2019-01-19 | 2019-02-09 | Capecitabine | N | N | 280028399 | IRINOTECAN + VINCRISTINE |
| 280011798 | 280006754 | 1.87 | 68.7 | Palliative (P) | 2014-06-25 | 2015-01-09 | LANREOTIDE | N | N | 280028689 | VIDE |
| 280011799 | 280009507 | 0 | 81.2 | null | null | 2017-02-03 | PEMBROLIZUMAB | N | null | 280029612 | ERIBULIN |
| 280011800 | 280006771 | null | null | Palliative (P) | 2016-12-16 | 2016-12-21 | DABRAFENIB + TRAMETINIB | N | null | 280017205 | CARBO + FLUOROURACIL |
| 280011801 | 280009516 | 1.71 | 79.5 | Palliative (P) | 2019-05-20 | 2019-07-02 | IVADo | N | N | 280023737 | CAPECITABINE + CISPLATIN |
| 280011802 | 280009517 | 1.61 | 90.2 | null | 2016-11-25 | 2017-02-27 | Carboplatin + Pemetrexed | N | N | 280023786 | CARBOPLATIN + CETUXIMAB + FU |
| 280011803 | 280010840 | 1.66 | 100 | Curative (C) | 2019-08-15 | 2019-08-16 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 280026551 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280011804 | 280004143 | 1.74 | 81 | Neo-adjuvant (N) | 2014-12-31 | 2015-01-06 | Cisplatin + Radiotherapy | null | null | 280000089 | CISPLATIN + RT |
| 280011806 | 280004237 | 1.66 | 109 | Curative (C) | 2015-01-17 | 2015-04-03 | Cisplatin + Radiotherapy | Y | null | 280006539 | CISPLATIN + RT |
| 280011807 | 280004259 | 1.73 | 105.4 | Palliative (P) | 2018-09-25 | 2018-10-02 | Trial Unspecified | 2 | N | 280007377 | TRIAL |
| 280011808 | 280004263 | 1.71 | null | Curative (C) | 2017-03-23 | 2017-04-04 | EW EuroEwing 2012 Arm B VDC | 2 | Y | 280007383 | TRIAL |